Hims & Hers Health Inc. (NYSE:HIMS) shares are up during Thursday’s premarket session as the company is accelerating its vision to become a leading global consumer health platform.

The positive movement follows the announcement of a definitive agreement to acquire Eucalyptus, a digital health leader, which is expected to enhance Hims & Hers’ international presence.

Hims & Hers agreed to acquire Eucalyptus, which operates in multiple countries, including Australia, the U.K., and Germany.

The deal is structured to maintain financial flexibility, with the company planning to finance most of the transaction using existing cash and future operating cash flows.

Deal Consideration

The transaction is valued at up to $1.15 billion. Approximately $240 million will be payable in cash upon closing of the acquisition.

The remaining consideration consists of guaranteed deferred payments over the 18 months following closing, and additional earnout payments tied to the attainment of specified financial targets through early 2029.

The acquisition is anticipated to close in mid-2026, allowing Hims & Hers to expand its reach into new markets such as Japan and Canada. This move is part of the company’s strategy to leverage local expertise and enhance its service offerings globally, aiming to provide ...